Product Information
AMRIX ER 30 MG CAPSULE is a brand product labeled by Cephalon, LLC, priced at $66.5671 per EA under NDC 63459070160. Its NADAC has been published 648 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the Cyclobenzaprine Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
30 mg/1
Manufacturer
Cephalon, LLCNDC
63459070160
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
1/1/2026
Active Ingredients
CYCLOBENZAPRINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA021777On Market Since
10/1/2007
Pharmacological Classes
Price Statistics
The NADAC for AMRIX ER 30 MG CAPSULE has been published 648 times since Nov 28, 2013, and over the history we have for it it has risen 242.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $66.5671 per EA |
|---|---|
| All-time high | $66.5671 (Jun 24, 2026) |
| All-time low | $19.3060 (Feb 19, 2014) |
| 52-week high | $66.5671 |
| 52-week low | $60.8474 |
| Median price | $40.4961 |
| Average price | $41.2528 |
| Largest weekly change | +9.9% (Jan 13, 2016) |
| Weeks tracked | 648 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of AMRIX ER 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for AMRIX ER 30 MG CAPSULE, manufactured by Cephalon, LLC, is $66.5671 per EA (NDC 63459070160), effective Jun 24, 2026.
How has the price of AMRIX ER 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for AMRIX ER 30 MG CAPSULE has risen 242.2%. It has been tracked across 648 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for AMRIX ER 30 MG CAPSULE?
Since Nov 28, 2013, the NADAC for AMRIX ER 30 MG CAPSULE has ranged from a low of $19.3060 (Feb 19, 2014) to a high of $66.5671 (Jun 24, 2026), with a median of $40.4961 per EA.
Are there cheaper alternatives to AMRIX ER 30 MG CAPSULE?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, CYCLOBENZAPRINE ER 30 MG CAP, is $0.8887 per EA — about 99% below AMRIX ER 30 MG CAPSULE.
Who manufactures AMRIX ER 30 MG CAPSULE?
AMRIX ER 30 MG CAPSULE (NDC 63459070160) is labeled by Cephalon, LLC, and CMS classifies it as a brand product.